TP53 and cancer: Drug-resistant cancer cells tend to express a series of membrane transporters represented by the ATP-binding cassette transporter (ABC) family to export diverse cytotoxic drugs, and in the meantime induce the mutation of proapoptosis genes like TP53 to escape from apoptosis, then resulting in the elevation of their endurance to the therapeutic agents.